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The exposome encompasses an individual's exposure to exogenous chemicals, as well as endogenous chemicals
that are produced or altered in response to external stressors. While the exposome concept has been established
for humanhealth, its principles can be extended to include broader ecological issues. The assessment of exposure
is tightly interlinked with hazard assessment. Here, we explore if mechanistic understanding of the causal links
between exposure and adverse effects on humanhealth and the environment can be improved by integrating the
exposome approach with the adverse outcome pathway (AOP) concept that structures and organizes the se-
quence of biological events from an initial molecular interaction of a chemical with a biological target to an ad-
verse outcome. Complementing exposome research with the AOP concept may facilitate a mechanistic
understanding of stress-induced adverse effects, examine the relative contributions from various components
of the exposome, determine the primary risk drivers in complex mixtures, and promote an integrative assess-
ment of chemical risks for both human and environmental health.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
The exposome expands our perception of lifetime exposure because
it integrates exogenous chemicalswith genetic and external factors that
generate chemicals inside the body and thereby may pose threats to
human health (Miller and Jones, 2014; Rappaport and Smith, 2010;
Wild, 2012). The external contribution to the human exposome is deter-
mined by environmental exposure, also termed the eco-exposome (Lioy
and Smith, 2013), such as exposure via air, food, water, dust, and use of
consumer products (Fig. 1). Apart from environmental pollutants and
their biotransformation products, the exposome includes endogenous
metabolites and markers of the adaptive cellular stress responses, as
well as chemicals that are generated in response to psychosocial stress
and lifestyle factors. These joint exposures can be related to adverse
health effects via exposome-wide association studies (EWAS;
Rappaport, 2012) without attempting to identify mechanistic causes
(Fig. 1). Importantly, these associations capture the joint effect of
many stressors acting in concert, which invokes mixture effects not
only in chemical space of exogenous and endogenous compounds, but
also mixtures in time, including the time dependence of effects. The
exposome has thus been advocated as a key to cumulative risk
assessment (Smith et al., 2015).
During the last decade, the exposome approach has mainly been
considered in epidemiology, while the complementary concept of
Adverse Outcome Pathways (AOP) has emerged in (eco)toxicology
(Ankley et al., 2010). The AOP concept links the exposure of chemicals
to their cellular concentrations and molecular initiating events (MIE),
through network/pathway disturbances and key events (KE) to re-
sponses at the cellular, organ, organismand,ﬁnally, population and eco-
system levels (Fig. 1). The AOP concept aims to enhance the utility of
Fig. 1.Multiple chemical exposures of the environment and their link via environmental media and the food chain to human exposure. Any type of exogenous chemical exposure will
change the endogenous exposure, both of which will elicit effects on cellular toxicity pathways. The cellular level might serve as integrator to understand both, the pathways to
adverse health outcomes as well as to ecosystem-level effects.
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mechanistic data for understanding and predicting adverse effects. It
also aligns in this goal with systems toxicology (Sturla et al., 2014)
and the Tox21 program, a joint initiative of the US National Institute of
Environmental Health Sciences (NIEHS) and the US Environmental
Protection Agency (EPA) (Betts, 2013; National Research Council,
2007). While the concepts of AOP and cellular toxicity pathways
(Patlewicz et al., 2013) account for multiple pathways triggered by a
chemical or stressor and are per deﬁnition chemical agnostic, most ex-
amples that applied these concepts in risk assessment to date are limit-
ed to individual chemicals, lacking an explicit treatment of internal
biotransformation and of combined effects resulting fromnon-chemical
stressors and chemical mixtures. Moving from linear AOPs to AOP net-
works is one step closer towards the idea of integrating both the
exposome approach and the AOP concept (Fig. 1). We argue that the
AOP concept can expand applications of the exposome beyond EWAS
to establish mechanistic understanding of the causal linkages between
chemical exposure and adverse effects. In turn, the exposome approach
can help the AOP concept grow beyond single chemicals to include the
effect of jointly acting mixtures that include both chemical and non-
chemical stressors.
In addition, we may proﬁt from the analogy of the environmental
and human exposure via the food chain and other uptake pathways
via air, water, dust, and consumer-products (Fig. 1).We consider exper-
imental tools that can connect both research arenas to better under-
stand well-conserved effects on the cellular level – emphasizing
commonalities and differences between the anthroposphere and the
ecosphere.
Here we ﬁrst explore the history of the exposome and AOP concepts
and then propose to use tools from systems chemistry and systems bi-
ology to integrate exposome and AOP concepts. We then conclude
with recommendations for further research.
1.1. Deﬁning relevant exposure
1.1.1. Exposome
In 2005,Wild coined the term “exposome” to describe the entireness
of environmental exposure that, as a complement to the genome, may
provide important clues for the understanding of chronic diseases. In
his concept, the exposome encompasses lifetime environmental expo-
sures that include lifestyle factors from the prenatal period onwards
(Wild, 2005). From this view, an accurate assessment of a complete ex-
posure history is required to understand the complex interplaywith ge-
netic susceptibility, since the majority of genetic alterations will
contribute to population disease burden only in the presence of speciﬁc
environmental exposures (Vineis et al., 2001; Wild, 2005).
Rappaport and Smith reﬁned the approach through emphasizing the
role of the chemistry in the organism, deﬁning the exposome as the to-
tality of human exposures from all exogenous and endogenous sources
in the “internal chemical environment” (Rappaport and Smith, 2010).
This latter deﬁnition takes into account that exposures are comprised
not only of chemicals entering the body from the environment (e.g.,
air, food, water, dust), but also include compounds produced in the
body by inﬂammation, (oxidative) stress, lipid peroxidation, infections,
the microbiome, and other natural processes (Fig. 2). The internal
chemical environment is highly dynamic during lifetime due to
(environmental) external and internal factors and processes such as
aging, infections, lifestyle, preexisting diseases etc. (Rappaport, 2011;
Rappaport and Smith, 2010).
The above-mentioned deﬁnitions of the exposome have their
speciﬁc merits depending on the angle from which exposure is viewed.
“Bottom-up” strategies focus on pre-selected compounds or compound
adducts following targeted hypotheses. By contrast, “top-down” strate-
gies aim at measuring all chemicals or products of their downstream
processing in a subject's biospecimen, such as blood (Rappaport,
2011; Rappaport and Smith, 2010), as far as technically feasible. Howev-
er, the full characterization of the exposome throughout the whole
lifespan remains an outstanding challenge.
1.1.2. Eco-exposome
While the exposome was originally deﬁned to characterize human
exposures, the idea can certainly be adapted to consider ecosystem ex-
posure. In 2012, the National Research Council (NRC) of the US National
Academy of Sciences deﬁned the “eco-exposome” as “the extension of
exposure science from the point of contact between a stressor and re-
ceptor inward into the organism and outward to the general environ-
ment, including the ecosphere” (National Research Council (NRC),
2012). Similar to the extended deﬁnitions of the human exposome,
the eco-exposome is described by both internal and external measures
of exposure (Lioy and Smith, 2013). Naturally, the implementation of
the exposome approach is speciﬁc for each biological species. However,
conservation of targets for drugs and chemicals on the cellular level
(Gunnarsson et al., 2008) might allow links to be found across species
and between humans and ecosystems (LaLone et al., 2014;
Rand-Weaver et al., 2013). The exposome narrative could establish an
important link between human and ecosystem health by examining
the effect of the totality of exposure from exogenous and endogenous
sources over all levels of biological organization and complexity
(Fig. 1). Although the eco-exposome adds another level of complexity,
shared toxicity pathways and adaptive stress responses can be invoked
to identify commonalities (Kramer et al., 2011), and variations in meta-
bolic and functional traits may explain differences (Forbes and Galic,
2016).
There are examples where elements of exposome research have
been applied in ecotoxicology, such as monitoring contaminants in
whole organisms (Houde et al., 2011; Lana et al., 2014; Lehnert et al.,
2016) or correlative studies associating functional health parameters
with body burdens of organic pollutants in marine wildlife (Jin et al.,
2015). Similarly to exposome research in human health, there has
been a focus on exposure assessment without necessarily establishing
a quantitative link to adverse effects. Hence, the challenges of, both,
the human exposome and eco-exposome are similar and there is mutu-
al beneﬁt for generating mechanistic knowledge.
1.2. Application of the AOP concept in the context of exposome research
A major motivation for developing the AOP concept was to support
the risk assessment of chemicals by providing mechanistic knowledge
that would enable to link in vitro (Andersen et al., 2005), in chemico
(Böhme et al., 2009) or in silico information (Rusyn and Daston, 2010),
including computational biotransformation (Ji and Schüürmann,
2013) and structural alerts (Schüürmann et al., 2016), to toxicity in
vivo (Berggren et al., 2015; Edwards et al., 2016). The AOP concept sup-
ports the validation of predictivemodels based on underlyingmolecular
mechanisms. This would allow a more efﬁcient use of high throughput
screening (HTS) to prioritize a large number of compounds for detailed
testing and/or reducing the number of animal experiments (Hartung et
al., 2013b). Furthermore, within a regulatory framework of integratedFig. 2. Deﬁning the exposome.
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assessment, AOPs can support a new, more targeted safety testing regi-
men that is focused on the most probable and relevant hazards (Rovida
et al., 2015; Tollefsen et al., 2014). Rather than apical endpoints typically
assessed for regulatory purposes, subchronic or sublethal endpoints, as
well as in vitro bioassays related to acute and chronic adverse effects,
may be used for establishing AOPs. The AOP concept has the inherent
promise to evolve from a tool for structuring knowledge or prioritiza-
tion of testing to a quantitative predictive tool to relate exposure data
to adverse outcomes (AO). However, challenges remain that concern
for example the incorporation of toxicokinetics as important determi-
nant of toxicity in AOPs and extrapolations to higher levels of biological
organization and across species (Groh et al., 2015). Thus, substance or
species-speciﬁc differences in the toxicokinetics and genetically based
differences across species can inﬂuence single events or processeswith-
in an AOP cascade, in consequence augmenting or mitigating apical ad-
verse effects.
1.2.1. How could the exposome approach and the AOP concept cross-fertilize
each other?
Initially, the exposome and the AOP concepts evolved separately in
the ﬁelds of human toxicology and ecotoxicology, respectively. The in-
clusion of biological response in exposure assessment is where AOPs
integrate into the exposome; the consideration of endogenous and
non-chemical stress as well as mixture effects is where the exposome
can enrich the AOP concept. Per deﬁnition, the exposome is speciﬁc
for individuals and integrates lifetime exposure while the AOP is con-
ceptually focused on biological mechanisms and pathways. The tempo-
ral aspects of the exposome are at least partially implemented in the
AOP concept. For instance, life-stage speciﬁcity or chronic toxicity
would address effects that are related to long-term or potentially re-
peated exposure scenarios and biological responses.
The system-wide analysis of biological responses employing
toxicogenomics represents an unbiased approach to detect chemical ef-
fects, integrating from MIEs along toxicity pathways (Berninger et al.,
2014; Ellinger-Ziegelbauer et al., 2009). However, large numbers of sig-
nals compromise the response signatures (Vidal-Dorsch et al., 2016)
and may lead to over-ﬁtted associations with exposure characteristics.
This calls for a reduction in data dimensionality through mechanistic
reasoning and biomarker identiﬁcation (Blaauboer et al., 2012) to dis-
criminate relevant signals from epi-phenomena and random responses
(Hartung et al., 2012). In this respect the combination of AOP and
exposome is revisiting previous approaches to apply biomarkers in ep-
idemiology (Toniolo et al., 1997). A biomarker may represent a KE lead-
ing to adverse outcomes butmay also represent events that are without
direct relevance to the adverse effect, e.g. representing a compensatory
reaction. However, the AOP concept is stricter and clearer with respect
to the relation of events that are directly related to adverse effects and
hence, its combination with the exposome could improve the relation
of exposome signals to impacts on health.
AOPs could further help to anchor system-wide responses to domi-
nant modes or mechanisms of action (Ellison et al., 2016), and thus in-
crease the conﬁdence in a hypothesis by providing mechanistic
plausibility (Braun et al., 2016).
1.2.2. Aggregate exposure pathways (AEPs), AOPs, and the exposome
The exposomemay also be considered as the integration of AEPs and
AOPs on (complex) mixtures if the source and pathways leading to the
internal exposure are included (Fig. 3). The AEP concept has been devel-
oped complementary to the AOP describing the KEs from source via ex-
ternal exposure (including environmental and dietary exposure) to
exposure in the organism, termed target site exposure (Teeguarden et
al., 2016), which is the crucial step linked to the molecular initiating
events of the AOP. Similar to AOPs, the AEPs help to organize exposure
information from exogenous source to internal site of action, setting
the stage for inferring chemical concentrations at the internal target
site and informing about expected biological effects.
The chemicals in the exposome constitute not only the exogenous
chemicals transported into the body and their metabolites, but also ad-
ducts with cellular constituents and other endogenous compounds, as
well as signaling molecules formed as part of the pathway of toxicity
(Kleensang et al., 2014) or adaptive stress responses (Simmons et al.,
2009; Smirnova et al., 2015) (Fig. 3). The formation of chemical adducts
can be considered asMIE,while endogenous chemicals (e.g. reactive ox-
ygen species, nitric oxide, ATP, glutathione) formed or changed in their
levels as part of the stress response belong to the KE. Aligning the
chemicals in the exposome to the various steps of the AEP/AOP
(Fig. 3) will help to establish a clearer a priori mechanistic link between
the exposome and adverse health outcomes, with some endogenous
chemicals of the exposome involved in defense against rather than in
the development of the disease. However, the internal chemical re-
sponse of stressed/perturbed organisms (e.g., due to an infection or an
unhealthy lifestyle) may potentially lower the repair capacities, which
may result in the next downstream event. These speciﬁc cases should
be addressed in future studies.
1.2.3. Putative AOPs in exposome assessment
The AOP concept has been moving from the initial ideas of linear
pathways to networks of pathways (Knapen et al., 2015), which
Fig. 3. Interface between the (eco)exposome (in red), the aggregate exposure pathway (AEP, green) and adverse outcome pathway (AOP, blue). The red dashed boxes represent chemical
components of the exposome. TheAEP/AOP concept allows one to disentangle key events and allocate them to steps from the source of exposure to adverse effects. The grey boxes indicate
experimental methods to quantify the chemical components of the exposome and the biological components of the AOP. Figure partially adapted from Teeguarden et al. (2016). (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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accommodates the idea of multiple causes for adverse effects. Some
scientists criticize that AOPs are presently often incomplete. However,
partial information on KEs and their relation even in case of weak evi-
dence can provide initial steps to prioritize areas that require further in-
vestigation, and to identify the most relevant (internal) exposure
situations. The AOP deﬁnitions and development are supported and
guided by the OECD on a global level (Worth et al., 2014). Putative
AOPs can be validated by the same principles that apply to AOPs in gen-
eral, that is, their consistency with scientiﬁc literature and evidence for
mechanistic links has to be demonstrated (Bell et al., 2016; Hartung et
al., 2013a). Furthermore, putative and partially incomplete AOPs with
high conﬁdence relationships between KEs can be useful in speciﬁc ap-
plications, such as predicting an adverse outcome based on an easily
tested KE (Perkins et al., 2015).
1.2.4. Grouping of exposures with converging AOPs
Given the large chemical variability, a full characterization of all pos-
sible MIEs and pathway-speciﬁc KEs remains one of the greatest chal-
lenges of future research. However, many AOPs converge at a higher
level of biological organization and the AOP-based assessment could
be conducted at more downstream KEs using cellular or organ re-
sponses. Examples include neuroactive pesticides or compounds
disrupting the thyroid axis. Many pesticides act by interferingwith spe-
ciﬁc steps in neural signal transduction that converge at the level of the
cardiovascular system leading to a respiratory failure syndrome and ﬁ-
nally death of the organism (Bradbury et al., 2008). Hence, characteriza-
tion of behavioral responses could allow the integration of various
mechanisms and to comprehensively describe exposure to neurotoxic
compounds. Compounds disrupting the thyroid hormone system pro-
vide related examples in human toxicology. While various different
MIEs are known, they ﬁnally converge at the intracellular or systemic
thyroid hormone level (Murk et al., 2013). Hence, an integrative assess-
ment could be based on test systems that target hormone levels in an
organism, e.g., by assessment of compensatory responses to reduced
thyroid hormone levels (Fetter et al., 2015).
1.2.5. Quantitative versus qualitative AOPs
Most AOPs are initially developed based on qualitative, mechanistic
evidence without consideration of toxicokinetics, i.e. the uptake, distri-
bution and metabolism/elimination of a compound in an organism.
However, the cellular concentration is a major driver of the magnitude
of the ﬁnal adverse effect. In the case of, e.g., a limited uptake or rapid
metabolism, adverse effects may be mitigated even for a high afﬁnity
to the molecular target (Patlewicz et al., 2013).
Quantitative AOPs (qAOP) build on approaches for toxicokinetic-
toxicodynamic (TKTD) modeling (MacKay et al., 2013) as was shown
very recently for a qAOP developed for effects of synthetic glucocorti-
coids in ﬁsh (Margiotta-Casaluci et al., 2016). If the AOP cannot be
fully described, hazard ratesmay be established to obtain a quantitative
link to the ﬁnal adverse effect (Ashauer et al., 2015).
1.2.6. Networks of AOPs for mixtures
If bioassays can be mapped to KEs in AOPs of speciﬁc chemical do-
mains, AOP networksmight be used for assessing the complexmixtures
of the exposome. Studies on extracts of environmental samples have
demonstrated how complex chemical mixtures can be characterized
using a battery of different mechanistic bioassays (Escher et al., 2014)
or transcriptomic tools (Berninger et al., 2014). The levels of single
chemicals will often fall below detection limits (both for chemical anal-
ysis and biological responses), but their combined exposuremay never-
theless generate detectable biological responses (Altenburger et al.,
2012; Silva et al., 2002). An AOP-based approach could help to interpret
effects of mixtures without necessarily resolving each component, e.g.,
if a mixture of chemicals is extracted from biospecimens and the
resulting extract is applied to cell-based bioassays (Altenburger et al.,
2015). Bioanalytical assessment of these extracts with cell-based
bioassaysmay support the identiﬁcation of themost relevant chemicals
and toxicity pathways interfering with human and wildlife health, pro-
vided that the bioassays are anchored in a deﬁned step of the AOP
(Busch et al., 2016). Identiﬁcation of such risk drivers could deﬁne
new target chemicals in (bio)monitoring programs.
The requirements for AOPs to be used for mixtures do not deviate
principally from those for AOPs for single compounds (Altenburger et
al., 2015). However, similar adverse outcomes may be triggered by dif-
ferentMIEs that could jointly affect the same KE ormore complex inter-
actions could arise as is delineated by the complex role of low-dose
mixtures in carcinogenesis (Goodson et al., 2015). Hence, experimental
methods should focus on those KEs that can be expected to aggregate
the bioactivity of different compounds that bind to different target
sites but still converge into the same adverse outcome (Fig. 4A, Vogs
and Altenburger, 2016).
Current understanding of mixture effects offers this reasoning as an
explanation of whymixtures act according to concentration addition or
independent action and may still show a combined effect where the in-
dividual components occur at sub-threshold concentrations
(Altenburger and Greco, 2009). So far, the predictive power of mixture
models has been demonstratedmainly for artiﬁcially designedmixtures
and deﬁned apical endpoints (e.g., growth, survival) (Kortenkamp et al.,
2009). More complex and environmentally relevant mixtures have oc-
casionally been evaluated using the concentration addition assumption
(Tang et al., 2013). In the past, mixture analysis that used endpoints an-
ticipated to strongly relate to anMIE, such as toxicogenomic responses,
were often based on poorly designed studies and therefore remained in-
conclusive (Altenburger et al., 2012). For the extension of the principles
of mixture toxicity to the AOP concept it is thus necessary to explore
how AOPs originating from different MIEs may converge at the KE
and/or AO level and whether AOPs can be formulated for complex mix-
tures that cannot be resolved to an individual mechanism of action.
However, even when a mixture effect would appear to be linked to an
individual AOP, this AOP may not allow one to trace back to a certain
chemical or chemical class due to the large number of chemicals and
complex interactions within the overall exposome. Still, such a diagno-
sis would be informative because it would establish a mechanistic link
between exposure and adverse effects.
Furthermore, toxicodynamic models are at present not available for
mixtures. They would be an asset to quantitatively model and predict
adverse outcomes or diseases resulting from mixtures for which expo-
sure information is limited orwhere quantitative knowledge is available
only for a limited number of KEs (Fig. 4B). Suchmodels would also open
an avenue towards approaching temporal issues in adverse outcome as-
sessment such as non-continuous or sequential exposures.
1.3. The role of systems biology and chemistry in exposome and AOP
research
The methodological “glue” that links the exposome and AOPs con-
sists, largely, of systems biological and chemical methods (Fig. 3). Sys-
tems biology is characterized by (i) an initial massive parallel
experimental approach, aimed at determining one ormore levels ofmo-
lecular signatures (e.g., transcriptome, proteome,metabolome etc.); (ii)
an iterative integration of experimental approaches and computational
data analysis, and modeling, and (iii) the computational generation of
experimentally testable hypotheses (Garcia-Reyero and Perkins, 2011;
Hood et al., 2012; Ideker et al., 2001).
The complementary view on systems involvingmolecules with their
compartmental partitioning and reaction networks is called systems
chemistry. It addresses the organization of molecular feedback, ampliﬁ-
cation and information gain, and how these translate into the emer-
gence of system-level properties (Ludlow and Otto, 2008; Nitschke,
2009; Whitesides, 2015). In the context of the exposome, systems
chemistry may describe the interplay between exogenous and
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endogenous compounds including their dependence on the spatially
varying dose as well as on reactivity, time, and further system
properties.
Since chemistry underpins biological processes both in organisms
and in the environment, a way forward is to combine omics and analyt-
icswith computational tools. Interdisciplinary approaches and bioinfor-
matics tools may serve to identify perturbations in organisms and in the
environment, to deﬁne biomarkers of exposure and disease, and to inte-
grate information from all relevant levels of organization (Smith et al.,
2015). AOPs can be regarded as biological roadmaps alongwhich chem-
istry mediates the development of toxicological effects. Identiﬁcation
and quantiﬁcation of AOPs involve chemicals as both triggers and mod-
ulators of toxicity, and employ systems biology methods to reconstruct
regulatory pathways, and to assess perturbations and rewiring in bio-
logical networks (Fig. 3).
1.3.1. What to measure?
The ﬁrst step is to use advanced analytics for identifying and quanti-
fying exogenous and endogenous chemicals (Fig. 3). EWAS are limited
by the inherent deﬁnition of ‘exposure-wide’ that calls for untargeted
analytical approaches (Patel, 2016). Despite enormous advancement
in analytical methodologies in recent years, problems persist and only
a very small number of the thousands of compounds detectable in a
sample can actually be identiﬁed, leaving the largest fraction of
chemicals at the level of a known accuratemass (or molecular formula)
and retention time. Any improvements here rely strongly on a better as-
signment of likely structures for these peaks based on a prediction of
fragmentation, ionization, or chromatographic retention times support-
ed by more comprehensive mass spectra databases. In contrast to non-
targeted analysis, targeted approaches require initial hypotheses
regarding classes of analytes and thus cannot carry through on the
promise of ‘exposure-wide’ detection. Currently, efforts are under way
to develop automated workﬂows to analyze large analytical datasets,
including multivariate statistical approaches dealing with patterns of
chemical signals in relationship to adverse outcomes without
attempting identiﬁcation and quantiﬁcation of individual chemicals
(Patel, 2016).
The characterization of the impact of external factors on the internal
chemical environment calls for the use of omics and analytical tech-
niques (Fig. 3). In recent years, substantial progress has been made in
measuring small molecules and metabolites (metabolomics, Athersuch
and Keun, 2015), DNA adducts (adductomics, Phillips et al., 2014;
Rappaport et al., 2012) or largemolecules, such as proteins and peptides
(proteomics, Stallman Brown, 2012).
Transcriptomics – except emerging techniques to detect chemically
modiﬁed RNA – does not identify products of external stress directly,
but has proven valuable for characterizing responses to exposure at
the pathway level. The transcriptome is easily assessed - also in cohort
studies - since it can be applied even if only little material down
to single cells is available. By combining transcriptomics with
classiﬁer analysis, more targeted endpoints can be developed
(de Boer et al., 2015).
Also of interest is the assessment of environment-induced epigenet-
ic changes, some of which have been shown to persist for prolonged pe-
riods of time (Bauer et al., 2016; Guida et al., 2015). Epigenomics may
thus provide stable biomarkers for past exposures that are not detect-
able due to a limited sampling scheme by other omics layers. However,
interpretation of epigenomic data remains challenging and functional
assessment of epigenomic changes frequently requires integration
with other omics data sets.
To assist in interpreting large-scale exposure data, the AOP concept
may help to establish mechanistic links to external perturbation, for ex-
ample by high-throughput screening of chemical interference with spe-
ciﬁc cellular toxicity pathways. Reporter gene assays based on nuclear
receptors and transcription factors of cellular toxicity pathways have
become popular tools not only to quantify exposure, but also to identify
relevant steps of the AOP triggered by chemicals and their complex en-
vironmental mixtures (Fig. 3).
Fig. 4. (A) AOP formixtures and (B) qAOPmixturemodeling concept for similar action. Adaptedwith permission fromVogs, C. and Altenburger, R. (2016) Time-Dependent Effects in Algae
for Chemicals with Different Adverse Outcome Pathways: A Novel Approach. Environmental Science & Technology, 50(14): 7770–7780. Copyright (2016) American Chemical Society.
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1.3.2. Where to measure?
In human exposomics, several biospecimens are appropriate for
assessing the internal chemical environment. Urine can be sampled
non-invasively, but favors the detection of water-soluble chemicals, in-
cludingmetabolites and conjugates. Measuring the blood exposome is a
sensible approach compared to organ-speciﬁc samples (Rappaport et
al., 2014). Blood transports chemicals to and from tissues and represents
a reservoir of many endogenous and exogenous chemicals in the body
at a given time (Nicholson et al., 2012). Blood samples are collected in
most cohort studies, are therefore easily accessible, and sometimes a
drop of blood is sufﬁcient for biomonitoring studies (Mao and Wang,
2015).
In eco-exposomics, integrating external with internal exposure has
practical but also theoretical implications: In small aquatic invertebrates
or ﬁsh embryos, the whole organisms need to be extracted. Analysis of
whole organisms is based on extracts from a poorly deﬁned mixture
of lipids, proteins, carbohydrates, and bodily ﬂuids. For larger organisms
withmore complex exposure pathways, such asmammals, larger ﬁsh or
birds, the exposome may be investigated in bodily ﬂuids similar to the
human exposome approach.
The AOP components involving MIEs and pathway responses in key
processes, such as development, are often evolutionarily conserved be-
tween human and model organism. Cross-species comparison focused
on conserved KEs allows for AOP anchoring, assuming that evolutionary
conserved proteinsmay have conserved functions. Therefore identiﬁca-
tion of protein orthologs through sequence similarity or other methods
might be helpful to infer susceptibility, particularly if anAOPhas already
been identiﬁed (Perkins et al., 2013). Differences between species that
cannot be captured by this approachwould be toxicokinetic differences,
especially with respect to metabolism.
1.3.3. When to measure?
The human exposome is highly variable and dynamic throughout
the human lifespan. The time-dependence of the exposome poses a
challenge for the integration with the AOP concept. AOPs so far do not
adequately reﬂect when KEs or KE relationships are only valid during
a certain life stage or developmental phase.
Routine measurements, in particular during critical life stages, such
as fetal development (cord blood analysis), early childhood, and puber-
ty, are key to establishing a personalized picture of speciﬁc individuals'
exposures (Rappaport and Smith, 2010). Time-sequenced information
on individual exposome at different time points prior to disease onset
would be of immense relevance for identifying environmental causes
of disease.
Human life-long exposure may leave its traces in the exposome,
while a retrospective analysis of external exposure along all uptake
pathways is impossible. For small and short-lived aquatic organisms,
however, intelligent environmental sampling regimes yield time-inte-
grated and peak exposures, bringing us close to the ideal of an assess-
ment of life-long exposure to external chemicals.
1.3.4. From exposome to adverse outcomes
Systems biology and chemistry tools may be linked to prioritize
compounds for chemical analytics by a tiered approach: Starting from
a population cohortwith a nested case-control study – “meet in the mid-
dle” approach that combines bottom-up and top-down approaches
(Vineis et al., 2013) – omics data from epigenomics, proteomics or tran-
scriptomics are generated and used to identify pathways/networks po-
tentially affected by exposures and subsequently driving disease risk.
For these pathways, in silico exploitation of (toxicological) databases
and chemical bioactivity from HTS, reporter gene assays and docking
studies will yield pathway-associated exogenous and endogenous
chemicals (Fig. 3).
Tox 21 and ToxCast have demonstrated the practicality of combining
(hundreds of) HTS screens with in vitro bioassays for more than 8000
single compounds (Tice et al., 2013). While the current focus is in vitro
to in vivo extrapolation using toxicokinetic models (Phillips et al.,
2016;Wetmore et al., 2013), these in vitro bioassays can also be applied
to monitor unknown mixtures in environmental samples from water
(Escher et al., 2014) to biota (Jin et al., 2015) and human specimens.
In this regard, in vitro assaysmay be useful to capture endogenous expo-
sures and changes in internal of stress.Methods to link causewith effect,
such as effect-directed analysis, are well established for the analysis of
the external exposure in water (Brack et al., 2016) or sediment (Brack
et al., 2005) and are increasingly applied tomammals and ﬁsh bio-ﬂuids
and tissues. Mode-of-action-speciﬁc bioassays have been used together
with fractionation approaches and untargeted analysis to identify
drivers of potential adverse effects in wildlife (Houtman et al., 2007;
Simon et al., 2013).
Certainly, not all prerequisites for such an approach are currently
available. The link between pathway perturbation and MIE may not be
traceable for a particular omics data set, speciﬁcally when lacking data
for the appropriate time points. However, the increasing capability to
acquire multi-omic data sets at several time-points in population co-
horts and environmental populations, combinedwith the use of deﬁned
in vitro HTS tools (Tuﬁ et al., 2016), may alleviate this issue.
1.3.5. Systems biology challenges in exposome research
Depending on the kinetics between initial exposure, MIEs and sub-
sequent adaptations, different levels of molecular responses may re-
quire analysis (Yugi et al., 2016). Regarding prenatal exposure, long-
term health effects might be accessible through epigenetics, whereas
themetabolome level appears best for immediate effects induced by en-
vironmental chemicals.
Cross-omics data integration is particularly relevant for AOP con-
struction: the multi-scale nature of AOPs calls for integrating more
than one omics layer. Single-cell pathway level effects will most
likely be studied using respective proteomics or transcriptomics,
whereas the organismal and population effects might be more easily
captured using serummetabolomics. Currently available approaches
reach their limits when the need arises to capture complex non-lin-
ear relationships between different omics data sets such as feedback
loops.
Omics data used for network inference and pathway analysis
should ideally be assessed in a time-resolved manner (Bar-Joseph
et al., 2012). Most methods used for network reconstruction do not
model time explicitly (Hempel et al., 2011) and more recent
methods that do may demand further analysis to fully assess their
potential (Le Novere, 2015).
2. Conclusions
2.1. How the AOP concept enhances understanding the exposome and its
impact on adverse outcome
An inspection of publications on AOP and exposome from the past
decade indicates that the concepts are widely accepted and intensively
discussed but that examples of practical applications remain scarce. It
can be anticipated that this will change in the near future provided
that application of the concepts in research are intensiﬁed. While both
concepts are in the midst of development, their integration might lead
to synergy, which will be promoted by early harmonization of data
collection and terminology.
The exposome approach and the AOP concept are essentially
orthogonal with the AOPs covering single pathways over the entire
effect chain while the exposome covers a multitude of pathways,
with the exposure in principle integrated over the lifetime but in
practice as cross sectional studies at a ﬁxed time over a population.
Thus, the crossing points of AOP and exposome will need to be ex-
panded in both dimensions.
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To further explore the utility and beneﬁt of future application of
AOPs in exposome assessment the following research topics need to
be strengthened:
1) More AOPs should be developed and deposited in central databases
(e.g., https://aopwiki.org/). With every new AOP developed the ca-
pacity of exposome assessment based on biological responses will
increase signiﬁcantly.
2) Evolutionarily conserved cellular toxicity pathways may serve as
common denominators for integrated effect assessments. We advo-
cate the use of KEs across species for a systems biology-assisted ap-
proach to exposome assessment.
3) Chronic exposure (both in terms of exposure duration and delay
of effects) represents the typical environmental situation and is
most relevant for human health. AOPs for chronic toxicity are at
present not well-described (Groh et al., 2015). However, one ex-
ample for a chronic AOP is described in the AOP wiki, i.e. “Chronic
binding of antagonist to N-methyl-D-aspartate receptors
(NMDARs) during brain development induces impairment of
learning and memory abilities” (https://aopwiki.org). Further-
more, many other endpoints, such as reproductive dysfunction
originating from endocrine disruption are of relevance only in
case of a chronic exposure since short-term exposures may not
lead to signiﬁcant population decline. Hence, an AOP-based
exposome assessment should target chronic endpoints and dis-
ease outcomes.
4) The research question is an important driver of the type of
exposome/AOP research, such as the identiﬁcation of the main
chemical risk drivers in relation tomode of action, the complexmul-
tifactorial inﬂuences ofmixtures or identiﬁcation of a threshold level
that can explain adverse effects.
2.2. Mixtures
Existing mixture models have to be adapted and tested with regard
to the AOP and exposome concepts. How established mixture toxicity
models can be applied to different KEs that lead to the same adverse
outcome remains a key question for future research.
2.3. Exposome characterization as a driver for risk assessment
Characterizing the exposome via untargeted measurement of an in-
ternal chemical environment promotes data-driven discoveries of caus-
al factors for human diseases or effects on the ecosystem. To identify the
sources and to develop prevention strategies, the main exposures have
to be characterized and validated by targeted techniques.Moreover, the
discrimination of different exposures also provides the basis for hypoth-
esis-driven research to promote mechanistic understanding. A promis-
ing approach to further develop such a mechanistic understanding
will be the use of the AOP concept as long as it is evolving further
from a linear pathway analysis to a tool to organize the complex net-
works of toxicity pathways.
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